Cancer incidence in adolescents and young adults in the United States, 1992-1997
- PMID: 12782451
- DOI: 10.1016/s1054-139x(03)00057-0
Cancer incidence in adolescents and young adults in the United States, 1992-1997
Abstract
Purpose: To examine cancer incidence patterns among adolescents and young adults in the United States.
Methods: Cancer incidence data from 26 population-based central cancer registries for 1992-1997 were used. Individual cancers were grouped into specific diagnostic groups and subgroups using an integrated classification scheme. The integrated scheme was developed for this study and was based on the most commonly used schemes in population-based epidemiologic studies: Surveillance, Epidemiology, and End Results Program's site groups, International Classification of Childhood Cancer, and International Agency for Research on Cancer's Histological Groups for Comparative Studies. Percent distributions and age-specific incidence rates per million population were computed for adolescents (aged 15-19 years) and young adults (aged 20-24 years) by gender.
Results: The data for 26,010 cancer cases were examined. Among 15-19-year-olds, the five most common cancers were Hodgkin's disease, leukemia, cancer in the brain and other nervous system, bone cancer, and non-Hodgkin's disease. Among 20-24-year-olds, the five most common cancers were Hodgkin's disease, testicular cancer, thyroid cancer, melanoma of the skin, and leukemia. The proportions and rates of the histologic subtypes for most of the common cancers changed with advancing age. For example, among 15-19-year-olds, acute lymphocytic leukemia accounted for approximately 60% of leukemias in males and 50% in females. Among 20-24-year-olds, however, the corresponding percentages of acute lymphocytic leukemia were 37% in males and 31% in females. For ovarian cancer, the germ cell tumor was the most common subtype (54.6% of all ovarian cancers) among 15-19-year-olds. In contrast, ovarian carcinoma was the predominant subtype (70.4%) among 20-24-year-olds. For both age groups, the incidence rates of nodular Hodgkin's disease, melanoma of the skin, and thyroid cancer were significantly greater in females than in males.
Conclusions: Cancer incidence patterns among adolescents and young adults are distinctive. In these age groups, a transition from predominantly pediatric histologic subtypes to adult subtypes was observed for Hodgkin's disease, leukemia, ovarian cancer, and soft tissue sarcoma. Gender differences were found for Hodgkin's disease, melanoma of the skin, and thyroid cancer.
Comment in
-
Commentary on "Cancer incidence in adolescents and young adults in the United States, 1992-1997".J Adolesc Health. 2003 Jun;32(6):403-4. doi: 10.1016/s1054-139x(03)00129-0. J Adolesc Health. 2003. PMID: 12782450 No abstract available.
Similar articles
-
Childhood cancer.Cancer. 1995 Jan 1;75(1 Suppl):395-405. doi: 10.1002/1097-0142(19950101)75:1+<395::aid-cncr2820751321>3.0.co;2-w. Cancer. 1995. PMID: 8001010
-
Hodgkin's disease.Cancer. 1995 Jan 1;75(1 Suppl):357-69. doi: 10.1002/1097-0142(19950101)75:1+<357::aid-cncr2820751318>3.0.co;2-a. Cancer. 1995. PMID: 8001007
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
[Cancer in adolescents and young adults in France: Epidemiology and pathways of care].Bull Cancer. 2016 Dec;103(12):957-965. doi: 10.1016/j.bulcan.2016.09.020. Epub 2016 Nov 3. Bull Cancer. 2016. PMID: 27817857 Review. French.
-
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2018;47(4):203-211. doi: 10.17849/insm-47-04-1-9.1. Epub 2019 Jan 22. J Insur Med. 2018. PMID: 30668210
Cited by
-
Comparison of differentiated thyroid carcinoma recurrence and its clinical features in children of different ages.Oncotarget. 2017 Jul 18;8(29):48051-48059. doi: 10.18632/oncotarget.18229. Oncotarget. 2017. PMID: 28624796 Free PMC article.
-
Hematospermia: etiological and management considerations.Int Urol Nephrol. 2009;41(1):77-83. doi: 10.1007/s11255-008-9409-9. Epub 2008 Jun 19. Int Urol Nephrol. 2009. PMID: 18563615 Review.
-
Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations.Cancers (Basel). 2020 Oct 27;12(11):3146. doi: 10.3390/cancers12113146. Cancers (Basel). 2020. PMID: 33120984 Free PMC article. Review.
-
Children's Oncology Group's 2023 blueprint for research: Rare tumors.Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30574. doi: 10.1002/pbc.30574. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37458616 Free PMC article.
-
AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma.Cancer Med. 2016 Jul;5(7):1535-41. doi: 10.1002/cam4.698. Epub 2016 Mar 31. Cancer Med. 2016. PMID: 27037835 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources